Prognostic Significance of Transcript-Type BCR‐ABL1 in Chronic Myeloid Leukemia

by matteo molica, elisabetta abruzzese, massimo breccia
Published 2020-08-01

Insights into the optimal use of ponatinib in patients with chronic phase chronic myeloid leukaemia

by Matteo Molica, Emilia Scalzulli, Gioia Colafigli, Robin Foà, Massimo Breccia
Published 2019-02-01

TP53 Mutations in Acute Myeloid Leukemia: Still a Daunting Challenge?

by Matteo Molica, Carla Mazzone, Pasquale Niscola, Paolo de Fabritiis, Paolo de Fabritiis
Published 2021-02-01

Treatment free remission in chronic myeloid leukemia: Lights and shadows

by Matteo Molica, Nelida I. Noguera, Malgorzata Monika Trawinska, Giovanni Martinelli, Claudio Cerchione, Elisabetta Abruzzese
Published 2020-09-01

CD33 Expression and Gentuzumab Ozogamicin in Acute Myeloid Leukemia: Two Sides of the Same Coin

by Matteo Molica, Salvatore Perrone, Carla Mazzone, Pasquale Niscola, Laura Cesini, Elisabetta Abruzzese, Paolo de Fabritiis
Published 2021-06-01

Case Report: Very Late, Atypical Extra-Medullary Relapse in a Patient With Acute Promyelocytic Leukemia (APL) Rescued With a Transplant-Free Approach

by Matteo Molica, Carla Mazzone, Tiziana Ottone, Pasquale Niscola, Elisabetta Abruzzese, Stefano Fratoni, Maria Teresa Voso, Paolo de Fabritiis, Paolo de Fabritiis
Published 2021-06-01

Life-threatening autoimmune hemolytic anemia and idiopathic thrombocytopenic purpura: successful seletive splenic artery embolization

by matteo molica, Fulvio Massaro, Giorgia Annechini, Erminia Baldacci, Gianna maria D'elia, Riccardo Rosati, Silvia maria trisolini, Paola Volpicelli, Robin Foà, Saveria Capria
Published 2016-04-01